Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-22
2010-06-01
Noakes, Suzanne M. (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C436S004000
Reexamination Certificate
active
07727953
ABSTRACT:
Ac-Sar-Gly-Val-D-allo-Ile-Thr-Nva-Ile-Arg-ProNHCH2CH3Crystalline Form 1, ways to make it, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.
REFERENCES:
patent: 6716963 (2004-04-01), Henkin
patent: 6774211 (2004-08-01), Henkin
patent: 2002/0830650 (2002-04-01), Henkin
Polymorphism in Pharmaceutical Solids, edited by Brittain, 1999, Macel Dekker Inc., pp. 178-179, 185 and 219.
Concise Encyclopedia of Chemistry (1993), Walter de Gruyter, Berlin-New York.
Haleblian et al. Journal of Pharmaceutical Sience, Aug. 1969, vol. 58, No. 8, pp. 911-929.
Rouhi, A.M., Chemical & Engineering New, Feb. 24, 2004, pp. 32-35.
Sheikh Ahmad Y.
Tolle John C.
Abbott Laboratories Inc.
Gesicki Glen J.
Noakes Suzanne M.
LandOfFree
Crystalline form of a drug does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form of a drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form of a drug will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4237075